Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MBX-1416 by MBX Biosciences Inc for Hypoglycemia: Likelihood of Approval
MBX-1416 is under clinical development by MBX Biosciences Inc and currently in Phase I for Hypoglycemia. According to GlobalData, Phase I...